Boehringer Ingelheim, Evotec and bioMérieux launch AUROBAC THERAPEUTICS
Published on
![AUROBAC THERAPEUTICS](https://aurobac-tx.com/wp-content/uploads/2023/09/aurobac-default.jpg)
The resulting company, AUROBAC THERAPEUTICS SAS, will combine the best-of-best capabilities of the three founding companies towards developing a new precision medicine approach, from diagnosis to cure.